UNSPSC 85445109: The diagnosis of antispasticity drugs

In this classification, this covers the group of activities that yields a diagnosis of antispasticity drugs. Antispasticity drugs is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y46.8.

UNSPSC 85445109 The diagnosis of antispasticity drugs is a Commodity code whose nominal scope does not align with the recent state and local opportunities posted under it. The three most recent solicitations tagged to this code involve diagnostic imaging systems, special education contracted services, and temporary health professional staffing — none of which address antispasticity drug diagnosis. The mismatch suggests either a classification error in the source data or a divergence between the code's intended scope and how state and local procurement offices are applying it in practice. No state and local opportunities directly soliciting antispasticity drug diagnostic services, testing protocols, or related pharmaceutical guidance appear in the recent record.

The code shows little relevant activity for business development purposes under its nominal definition. Firms evaluating pursuit of state and local work in antispasticity drug diagnosis should verify code classification with specific issuing bodies before investing in RFP response infrastructure, as current posting practice does not reflect traditional pharmaceutical diagnostic procurement activity.